AT333963B - Verfahren zur herstellung von anasthesierend wirkenden injizierbaren zubereitungen - Google Patents

Verfahren zur herstellung von anasthesierend wirkenden injizierbaren zubereitungen

Info

Publication number
AT333963B
AT333963B AT1082571A AT1082571A AT333963B AT 333963 B AT333963 B AT 333963B AT 1082571 A AT1082571 A AT 1082571A AT 1082571 A AT1082571 A AT 1082571A AT 333963 B AT333963 B AT 333963B
Authority
AT
Austria
Prior art keywords
anasthesis
manufacturing
injectable preparations
injectable
preparations
Prior art date
Application number
AT1082571A
Other languages
English (en)
Other versions
ATA1082571A (de
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of ATA1082571A publication Critical patent/ATA1082571A/de
Application granted granted Critical
Publication of AT333963B publication Critical patent/AT333963B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT1082571A 1970-12-17 1971-12-16 Verfahren zur herstellung von anasthesierend wirkenden injizierbaren zubereitungen AT333963B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6006770A GB1379730A (en) 1970-12-17 1970-12-17 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ATA1082571A ATA1082571A (de) 1976-04-15
AT333963B true AT333963B (de) 1976-12-27

Family

ID=10484946

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1082571A AT333963B (de) 1970-12-17 1971-12-16 Verfahren zur herstellung von anasthesierend wirkenden injizierbaren zubereitungen

Country Status (11)

Country Link
AT (1) AT333963B (de)
AU (1) AU471022B2 (de)
BE (1) BE776788A (de)
CA (1) CA970281A (de)
DE (1) DE2162593A1 (de)
FR (1) FR2118120B1 (de)
GB (1) GB1379730A (de)
IE (1) IE36705B1 (de)
IL (1) IL38375A (de)
NL (1) NL7117255A (de)
ZA (1) ZA718463B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5581735A (en) * 1978-12-14 1980-06-20 Kao Corp Emulsifier composition
JP2655190B2 (ja) * 1989-06-21 1997-09-17 エスエス製薬 株式会社 コルチコステロイド含有軟膏剤
SE9302295D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab New pharmaceutical composition
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
CA3123002A1 (en) * 2018-12-10 2020-06-18 Halo Science LLC Stable formulations of anesthetics and associated dosage forms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL91070C (de) * 1900-01-01
DE1262509B (de) * 1962-04-19 1968-03-07 Hoechst Ag Verfahren zur Herstellung von waessrigen Loesungen von Steroidhormonen
FR6555M (de) * 1967-05-03 1968-12-23

Also Published As

Publication number Publication date
ATA1082571A (de) 1976-04-15
IE36705L (en) 1972-06-17
FR2118120A1 (de) 1972-07-28
DE2162593A1 (de) 1972-07-06
NL7117255A (de) 1972-06-20
CA970281A (en) 1975-07-01
IL38375A0 (en) 1972-02-29
AU471022B2 (en) 1976-04-08
ZA718463B (en) 1973-08-29
IL38375A (en) 1976-07-30
IE36705B1 (en) 1977-02-02
GB1379730A (en) 1975-01-08
AU3695971A (en) 1973-06-21
FR2118120B1 (de) 1976-04-16
BE776788A (fr) 1972-06-16

Similar Documents

Publication Publication Date Title
AT308105B (de) Verfahren zur Herstellung von Dibenzylaminofluoranverbindungen
AT320144B (de) Verfahren zur Herstellung von 7-Amino-3-methyl-3-cephem-4-carbonsäuren
AT313471B (de) Verfahren zur Herstellung von 7-Halogen-7-deoxy-lincomycinen
AT310714B (de) Verfahren zur Herstellung von 4-Oxocapronitril
AT333963B (de) Verfahren zur herstellung von anasthesierend wirkenden injizierbaren zubereitungen
AT322732B (de) Verfahren zur herstellung von 7-aminocephalosporansäuren
AT313878B (de) Verfahren zur Herstellung von Alkylophenolen
AT308075B (de) Verfahren zur Herstellung von Monochlorbenzaldehyden
AT306922B (de) Verfahren zur Herstellung von Erythromycylaminverbindungen
CH553758A (de) Verfahren zur herstellung von azidosulfonylcarbanilaten.
AT310960B (de) Verfahren zur Herstellung von 6α-Methyl-19-nor-pregnenen
AT306032B (de) Verfahren zur Herstellung von 4-Hydroxy-6-halogenmethyl-pyrimidinen
AT310769B (de) Verfahren zur Herstellung von ɛ-Caprolacton
AT306235B (de) Verfahren zur Herstellung von Erythromycylaminverbindungen
AT332970B (de) Verfahren zur herstellung von alkalipolyphosphatkomplexen von alpha -6-desoxy-5- hydroxytetracyclin
AT335078B (de) Verfahren zur herstellung von 3beta-hydroxy-5alfa-cardenoliden und -bufadienoliden
AT324546B (de) Verfahren zur herstellung von aminopenicillinen
CH558809A (de) Verfahren zur herstellung von penicillinen.
AT316508B (de) Verfahren zur Herstellung von Cyclopropylmethylalkylaminen
AT313926B (de) Verfahren zur Herstellung von Xylose
AT303379B (de) Verfahren zur Herstellung von Oligomeren
AT312583B (de) Verfahren zur Herstellung von Isothymol
CH522585A (de) Verfahren zur Herstellung von Metachlornitrobenzol
CH540230A (de) Verfahren zur Herstellung von Phenäthylamiden
CH557793A (de) Verfahren zur herstellung von sebacinsaeurediestern.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee